ALT
NASDAQ · Biotechnology
Altimmune Inc
$2.97
+0.04 (+1.37%)
Open$2.88
Previous Close$2.93
Day High$3.04
Day Low$2.88
52W High$7.73
52W Low$2.56
Volume—
Avg Volume3.90M
Market Cap525.08M
P/E Ratio—
EPS$-0.92
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+255.2% upside
Current
$2.97
$2.97
Target
$10.55
$10.55
$6.68
$10.55 avg
$11.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 96.2K | 232.2K | 252.74M |
| Net Income | -192,317,835 | -932,514,656 | 22.15M |
| Profit Margin | -214,861.0% | -451,530.3% | 8.8% |
| EBITDA | -206,031,468 | -1,065,342,972 | 31.01M |
| Free Cash Flow | — | — | 16.83M |
| Rev Growth | — | -83.5% | +1.7% |
| Debt/Equity | 0.15 | — | 0.20 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $234.76 | +2.07% | 105.2 | 382.49B |
| AMGN | Amgen Inc | $347.01 | +0.66% | 23.4 | 182.21B |
| GILD | Gilead Sciences Inc | $125.05 | +0.14% | 16.7 | 153.66B |
| VRTX | Vertex Pharmaceuticals Inc | $468.42 | +0.35% | 26.4 | 114.63B |
| REGN | Regeneron Pharmaceuticals | $618.03 | +0.90% | 14.5 | 63.95B |
| ALNY | Alnylam Pharmaceuticals Inc | $288.18 | +0.62% | 64.3 | 37.13B |